Skip to main content
TaxDollarData

Leidos Biomedical Research Inc.

Federal Contractor · Rank #109

Total Federal Spending
$869.3M
$869,311,933
Total Obligations
25
Total Awards
25
Contracts
1
Agencies

Spending by Agency

Recent Awards

DescriptionAgencyStart DateAmount
TAS::75 0849::TAS OPER OF GOVT R&D GOCO FACILITIESDepartment of Health and Human ServicesSep 26, 2008$4.8B
NCI OPERATIONAL TASK ORDERDepartment of Health and Human ServicesAug 31, 2020$1.8B
NCI FY25 OPERATIONAL TASK ORDERDepartment of Health and Human ServicesSep 28, 2024$398.9M
NIAID DCR OPERATIONAL TASK ORDER COVID FUNDING IN THE AMOUNT OF $3,706,224 FOR COVID RELATED EFFORTS ON THIS TASK ORDERDepartment of Health and Human ServicesAug 31, 2020$291.2M
NIAID COVID-19 ACTIV3Department of Health and Human ServicesSep 2, 2020$233.6M
THE OBJECTIVE OF THIS TASK ORDER SUPPORTS NIAIDS GOAL TO CONDUCT A SERIES OF STANDARDIZED PHASE 1 AND PHASE 2 TRIALS ON NEXT-GENERATION VACCINES TO GENERATE DATA TO INFORM DECISIONS ON WHICH CANDIDATES TO SUPPORT FOR ADVANCED DEVELOPMENT.Department of Health and Human ServicesJun 1, 2023$173.3M
MD NETDepartment of Health and Human ServicesSep 26, 2019$163.5M
CENTER FOR SEROLOGICAL SCIENCES NETWORK (SERONET)Department of Health and Human ServicesFeb 10, 2021$143.6M
ADVANCE UNIVERSAL INFLUENZA VACCINE - FLU MOSAIC VERSION 2 (FLUMOSV2)Department of Health and Human ServicesFeb 16, 2021$141.7M
FFRDC SPACE MANAGEMENT TASK ORDER (LEASES)Department of Health and Human ServicesAug 30, 2019$126.4M
NIAID VRCDepartment of Health and Human ServicesAug 31, 2020$121.5M
DCR IS REQUESTING THE SERVICES OF LEIDOS BIOMEDICAL RESEARCH, INC. TO INITIATE MANAGEMENT, OVERSIGHT, EXECUTION, CLOSEOUT AND PUBLICATION OF FINDINGS OF A PROSPECTIVE OBSERVATIONAL STUDY OF ADULT AND PEDIATRIC PATIENTS WITH UNKNOWN FEBRILE ILLNESS FRDepartment of Health and Human ServicesSep 28, 2020$97.5M
ON BEHALF OF NIAID-DCR, FACILITATE THE CONDUCT OF TWO, RANDOMIZED TRIALS AS DETAILED BELOW IN I AND II: I. A RANDOMIZED BLINDED CONTROLLED TRIAL OF THE SAFETY AND EFFICACY OF INVESTIGATIONAL THERAPEUTICS FOR THE TREATMENT OF COVID-19 (2,000 SUBJECTSDepartment of Health and Human ServicesApr 1, 2020$89.6M
ENABLING NCI CLINICAL & RESEARCH DATA SHARINGDepartment of Health and Human ServicesAug 31, 2021$80.9M
HHSN261201500003I; HHSN26100071; 400.021.0071.0001; NCI CBIIT; APPROPRIATED; EXPAND DATA COMMONS; 09/14/18-09/13/23Department of Health and Human ServicesSep 11, 2018$67.0M
NIAID DCR OPERATIONAL TASK ORDERDepartment of Health and Human ServicesAug 31, 2024$65.3M
DEVELOPMENT OF TARGET CHARACTERIZATION METHODS FOR NOVEL CANCER MARKERSDepartment of Health and Human ServicesSep 28, 2020$56.5M
EBOLA VIRUS AND OTHER INFECTIOUS DISEASESDepartment of Health and Human ServicesSep 30, 2018$56.4M
CELL-BASED IMMUNOTHERAPY PRODUCTSDepartment of Health and Human ServicesSep 24, 2018$53.5M
COVID ACTIV3 TASK ORDER SUPPORTS NIAID'S GOAL TO BETTER UNDERSTAND THE CORONAVIRUS WITH AN INITIAL FOCUS ON ACTIV3. THIS TASK ORDER WILL INITIATE THE MANAGEMENT , OVERSIGHT , AND CONDUCT OF THE NIAID DCR CLINICAL TRIAL TITLED A MULTICENTER, ADADepartment of Health and Human ServicesJun 30, 2020$50.0M

All federal spending data sourced from USAspending.gov, the official source for federal award data as mandated by the Government Accountability Office.

Leidos Biomedical Research Inc. Federal Contracts FAQ

Leidos Biomedical Research Inc. has received $869,311,933 in total federal obligations across 25 awards and 25 contracts.

Leidos Biomedical Research Inc. works with 1 federal agencies, including Department of Health and Human Services. The largest agency relationships are based on total dollar obligations.

Leidos Biomedical Research Inc. has received federal awards in multiple states.

Leidos Biomedical Research Inc. is ranked #109 among the largest federal contractors by total obligation amount. Rankings are based on USASpending.gov data for FY2024.

Sources: USASpending.gov, Federal Procurement Data System
Last updated:

Spending figures represent total federal obligations for FY2024, as reported through USASpending.gov. Rankings are based on aggregate obligation amounts across all contract, grant, and direct payment awards.

For this entity, the underlying data on this page comes from USASpending.gov federal awards data. The breakdown above is the federal record; the paragraphs below add the per-entity context that makes the headline numbers usable for a real decision rather than just a data lookup.

The methodology behind every numeric value on this page is publicly documented on the USASpending.gov federal awards data portal and described in detail on this site’s methodology page. Refresh cadence varies by underlying series; the page surfaces the as-of date for each number so readers can trace any figure back to the source release.

For readers using this page as a decision input, the related-entity pages elsewhere on the site provide the comparison set. The most useful comparison for this entity is typically a peer within U.S. federal contracts, grants, and awards with similar size, similar exposure, or similar geography — not the national-level summary alone.